Predicted protein targets (top 17)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | PRF1 | P14222 | 9/20 | 0.34 |
| ▸ | KMT2A | Q03164 | 2/20 | 0.34 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.34 |
| ▸ | MAPT | P10636 | 1/20 | 0.34 |
| ▸ | THRB | P10828 | 1/20 | 0.34 |
| ▸ | HPGD | P15428 | 1/20 | 0.34 |
| ▸ | RECQL | P46063 | 1/20 | 0.34 |
| ▸ | NPSR1 | Q6W5P4 | 1/20 | 0.34 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.34 |
| ▸ | APP | P05067 | 1/20 | 0.31 |
| ▸ | SNCA | P37840 | 1/20 | 0.31 |
| ▸ | EGFR | P00533 | 1/20 | 0.31 |
| ▸ | RET | P07949 | 1/20 | 0.31 |
| ▸ | KDR | P35968 | 1/20 | 0.31 |
| ▸ | CTRC | Q99895 | 1/20 | 0.31 |
| ▸ | MEN1 | O00255 | 1/20 | 0.30 |
| ▸ | PKM | P14618 | 1/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL21709685 | 0.95 | KMT2A (0.35) | PRF1KMT2AALDH1A1MAPTTHRB | |
| SCHEMBL20043835 | 0.88 | PRF1 (0.30) | PRF1 | |
| SCHEMBL20043994 | 0.87 | KMT2A (0.35) | KMT2AALDH1A1MAPTTHRBHPGD | |
| SCHEMBL21156746 | 0.87 | ALDH1A1 (0.30) | KMT2AALDH1A1MAPTTHRBHPGD | |
| SCHEMBL20044325 | 0.86 | MGAT2 (0.32) | PRF1ALDH1A1MAPTHPGDNPSR1 | |
| SCHEMBL21155817 | 0.86 | ALDH1A1 (0.32) | KMT2AALDH1A1MAPTTHRBHPGD | |
| SCHEMBL21156751 | 0.85 | ALDH1A1 (0.31) | KMT2AALDH1A1MAPTTHRBHPGD | |
| SCHEMBL20247155 | 0.85 | MGAT2 (0.30) | — | |
| SCHEMBL24637687 | 0.85 | EGFR (0.39) | PRF1KMT2AALDH1A1MAPTTHRB | |
| SCHEMBL20042489 | 0.85 | — | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-10991893-B2 | Organic semiconducting compounds | Raynergy Tek Incorporation (TW) | 2021-04-27 | — | — | US | disclosed |
| US-20200052227-A1 | ORGANIC SEMICONDUCTING COMPOUNDS | MERCK PATENT GMBH (DE) | 2020-02-13 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20200052227-A1 | ORGANIC SEMICONDUCTING COMPOUNDS | OCIAD2, OCIAD1, OSTC | PRF1 3167/4885KMT2A 916/4885ALDH1A1 2672/4885 |
| US-10991893-B2 | Organic semiconducting compounds | OCIAD2, OCIAD1, OSTC | PRF1 3167/4885KMT2A 916/4885ALDH1A1 2672/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.